vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Bath & Body Works, Inc. (BBWI). Click either name above to swap in a different company.
Bath & Body Works, Inc. is the larger business by last-quarter revenue ($1.6B vs $950.5M, roughly 1.7× Astrana Health, Inc.). Bath & Body Works, Inc. runs the higher net margin — 4.8% vs 0.7%, a 4.1% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -1.0%). Bath & Body Works, Inc. produced more free cash flow last quarter ($-1.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -26.0%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Bath & Body Works, Inc. is an American specialty retail company based in Columbus, Ohio. It owns Bath & Body Works, posted $7.4 billion in revenue in 2023, and was listed as 481 on the 2024 Fortune 500 list of largest United States companies by revenue.
ASTH vs BBWI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.6B |
| Net Profit | $6.6M | $77.0M |
| Gross Margin | — | 41.3% |
| Operating Margin | 1.9% | 10.1% |
| Net Margin | 0.7% | 4.8% |
| Revenue YoY | 42.9% | -1.0% |
| Net Profit YoY | 184.4% | -27.4% |
| EPS (diluted) | $0.12 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.6B | ||
| Q3 25 | $956.0M | $1.5B | ||
| Q2 25 | $654.8M | $1.4B | ||
| Q1 25 | $620.4M | $2.8B | ||
| Q4 24 | $665.2M | $1.6B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.4B | ||
| Q1 24 | $404.4M | $2.9B |
| Q4 25 | $6.6M | $77.0M | ||
| Q3 25 | $373.0K | $64.0M | ||
| Q2 25 | $9.4M | $105.0M | ||
| Q1 25 | $6.7M | $453.0M | ||
| Q4 24 | $-7.8M | $106.0M | ||
| Q3 24 | $16.1M | $152.0M | ||
| Q2 24 | $19.2M | $87.0M | ||
| Q1 24 | $14.8M | $579.0M |
| Q4 25 | — | 41.3% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 45.4% | ||
| Q1 25 | — | 46.7% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 41.0% | ||
| Q2 24 | — | 43.8% | ||
| Q1 24 | — | 45.9% |
| Q4 25 | 1.9% | 10.1% | ||
| Q3 25 | 2.0% | 10.1% | ||
| Q2 25 | 3.1% | 14.7% | ||
| Q1 25 | 3.3% | 24.3% | ||
| Q4 24 | 0.1% | 13.5% | ||
| Q3 24 | 5.9% | 12.0% | ||
| Q2 24 | 6.2% | 13.5% | ||
| Q1 24 | 7.5% | 23.9% |
| Q4 25 | 0.7% | 4.8% | ||
| Q3 25 | 0.0% | 4.1% | ||
| Q2 25 | 1.4% | 7.4% | ||
| Q1 25 | 1.1% | 16.3% | ||
| Q4 24 | -1.2% | 6.6% | ||
| Q3 24 | 3.4% | 10.0% | ||
| Q2 24 | 3.9% | 6.3% | ||
| Q1 24 | 3.7% | 19.9% |
| Q4 25 | $0.12 | $0.37 | ||
| Q3 25 | $0.01 | $0.30 | ||
| Q2 25 | $0.19 | $0.49 | ||
| Q1 25 | $0.14 | $2.06 | ||
| Q4 24 | $-0.14 | $0.49 | ||
| Q3 24 | $0.33 | $0.68 | ||
| Q2 24 | $0.40 | $0.38 | ||
| Q1 24 | $0.31 | $2.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $236.0M |
| Total DebtLower is stronger | — | $3.9B |
| Stockholders' EquityBook value | $779.3M | $-1.6B |
| Total Assets | $2.2B | $5.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $236.0M | ||
| Q3 25 | $463.4M | $364.0M | ||
| Q2 25 | $342.1M | $636.0M | ||
| Q1 25 | $260.9M | $674.0M | ||
| Q4 24 | $290.8M | $191.0M | ||
| Q3 24 | $350.3M | $514.0M | ||
| Q2 24 | $327.7M | $855.0M | ||
| Q1 24 | $337.3M | $1.1B |
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.4B |
| Q4 25 | $779.3M | $-1.6B | ||
| Q3 25 | $775.5M | $-1.5B | ||
| Q2 25 | $765.5M | $-1.5B | ||
| Q1 25 | $745.4M | $-1.4B | ||
| Q4 24 | $712.7M | $-1.7B | ||
| Q3 24 | $704.6M | $-1.7B | ||
| Q2 24 | $678.9M | $-1.7B | ||
| Q1 24 | $653.5M | $-1.6B |
| Q4 25 | $2.2B | $5.0B | ||
| Q3 25 | $2.2B | $4.8B | ||
| Q2 25 | $1.4B | $4.9B | ||
| Q1 25 | $1.3B | $4.9B | ||
| Q4 24 | $1.4B | $5.0B | ||
| Q3 24 | $1.3B | $4.9B | ||
| Q2 24 | $1.3B | $5.2B | ||
| Q1 24 | $1.2B | $5.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $80.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $-1.0M |
| FCF MarginFCF / Revenue | -0.6% | -0.1% |
| Capex IntensityCapex / Revenue | 0.3% | 5.1% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.04× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $946.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $80.0M | ||
| Q3 25 | $10.0M | $-43.0M | ||
| Q2 25 | $90.9M | $188.0M | ||
| Q1 25 | $16.6M | $955.0M | ||
| Q4 24 | $-10.9M | $-99.0M | ||
| Q3 24 | $34.0M | $-46.0M | ||
| Q2 24 | $23.2M | $76.0M | ||
| Q1 24 | $6.0M | $926.0M |
| Q4 25 | $-6.0M | $-1.0M | ||
| Q3 25 | $7.4M | $-99.0M | ||
| Q2 25 | $89.5M | $151.0M | ||
| Q1 25 | $13.6M | $895.0M | ||
| Q4 24 | $-13.5M | $-164.0M | ||
| Q3 24 | $31.7M | $-101.0M | ||
| Q2 24 | $20.4M | $30.0M | ||
| Q1 24 | $5.6M | $878.0M |
| Q4 25 | -0.6% | -0.1% | ||
| Q3 25 | 0.8% | -6.4% | ||
| Q2 25 | 13.7% | 10.6% | ||
| Q1 25 | 2.2% | 32.1% | ||
| Q4 24 | -2.0% | -10.2% | ||
| Q3 24 | 6.6% | -6.6% | ||
| Q2 24 | 4.2% | 2.2% | ||
| Q1 24 | 1.4% | 30.2% |
| Q4 25 | 0.3% | 5.1% | ||
| Q3 25 | 0.3% | 3.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.5% | 2.2% | ||
| Q4 24 | 0.4% | 4.0% | ||
| Q3 24 | 0.5% | 3.6% | ||
| Q2 24 | 0.6% | 3.3% | ||
| Q1 24 | 0.1% | 1.6% |
| Q4 25 | -0.44× | 1.04× | ||
| Q3 25 | 26.69× | -0.67× | ||
| Q2 25 | 9.65× | 1.79× | ||
| Q1 25 | 2.48× | 2.11× | ||
| Q4 24 | — | -0.93× | ||
| Q3 24 | 2.11× | -0.30× | ||
| Q2 24 | 1.21× | 0.87× | ||
| Q1 24 | 0.40× | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BBWI
| Bath Body Works Stores | $1.2B | 77% |
| Bath Body Works Direct | $299.0M | 19% |
| Bath Body Works International | $73.0M | 5% |
